GT Biopharma
GTBP • NASDAQ • Stock Fundamentals
GT Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Martin Breen, with a market cap of $14.1M.
Market Cap$14.1M
Employees2.0
CEOMichael Martin Breen
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
GT Biopharma FAQ
Common questions about GT Biopharma
GT Biopharma (GTBP) has a market capitalization of $14.1M and trades on NASDAQ.
GT Biopharma has approximately 2 employees.